GSK5926371

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Lymphoma, Non-HodgkinSystemic Lupus Erythematosus

Phase 1

A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)

RecruitingNCT07371468

GlaxoSmithKlineSystemic Lupus Erythematosus

Start: 2026-02-10End: 2028-03-15Target: 44Updated: 2026-06-23

A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL

Not yet recruitingNCT07607925

GlaxoSmithKlineLymphoma, Non-Hodgkin

Start: 2026-06-12End: 2029-09-24Target: 49Updated: 2026-06-18